Skip Navigation LinksHome > January 23, 2004 - Volume 18 - Issue 2 > Recombination following superinfection by HIV-1
AIDS:
Basic Science

Recombination following superinfection by HIV-1

Fang, Guoweia; Weiser, Barbaraa,b; Kuiken, Carlac; Philpott, Sean Ma; Rowland-Jones, Sarahd; Plummer, Francise; Kimani, Joshuaf; Shi, Binshana; Kaul, Ruperte,f; Bwayo, Jobf; Anzala, Omuf; Burger, Harolda,b

Free Access
Article Outline
Collapse Box

Author Information

From the aWadsworth Center, NY State Department of Health, Albany, the bDepartment of Medicine, Albany Medical College, Albany and cLos Alamos National Laboratory, Los Alamos, USA, the dInstitute of Molecular Medicine, University of Oxford, Oxford, UK, the eDepartment of Medical Microbiology, University of Manitoba, Winnipeg, Canada and the fDepartment of Medical Microbiology, University of Nairobi, Nairobi, Kenya.

Correspondence to Dr H. Burger, Wadsworth Center, 120 New Scotland Ave, Albany, NY 12208, USA.

Received: 22 May 2003; revised: 7 August 2003; accepted: 19 August 2003.

Collapse Box

Abstract

Background: There is increasing recognition of recombinant HIV-1 strains globally, but it has been unclear whether recombination results from superinfection during untreated, chronic infection.

Objective: To search for evidence of recombination and superinfection in Africa, where multiple HIV-1 subtypes facilitate identification of strains.

Methods: Serial blood samples from highly exposed, chronically infected women in Nairobi's Pumwani sex workers cohort were examined. Serial, complete HIV-1 RNA sequence analyses were performed for seven untreated long-term survivors. Sequences were subjected to computational analysis.

Results: One woman had evidence of both superinfection and recombination. Complete HIV-1 RNA sequences were first derived from plasma obtained in 1986, when the woman had been HIV seropositive for at least 21 months; this sequence was entirely subtype A. The sequences obtained from plasma in 1995 and 1997, however, were subtype A/C recombinants with a SimPlot demonstrating that the subtype A fragment in 1995 and 1997 was derived from the original 1986 A sequence. Heteroduplex tracking assays demonstrated that the subtype C sequences were not detectable as minor species in 1986.

Conclusion: Intersubtype recombination took place between the original non-recombinant subtype A strain and the superinfecting subtype C strain in an untreated, chronically infected woman. This finding helps to explain the rising prevalence of recombinant HIV-1 worldwide. Recombination resulting from superinfection with diverse strains may pose problems for eliciting broad immune responses necessary for an effective vaccine.

Back to Top | Article Outline

Introduction

Recombination among genetically distinct subtypes and strains of HIV-1 is now recognized with increasing frequency in the global pandemic [1-11]. Recombination provides a mechanism to increase viral sequence diversity rapidly, unlike the slow accumulation of mutations that occurs through replication errors [12]. For recombination to occur between distinct HIV-1 strains, a cell needs to be dually infected with different viruses [13]. The progeny virions that result possess RNA genomes from each virus, permitting strand-switching to occur during the next round of reverse transcription [12]. Therefore, recombination requires coinfection of viral strains in an individual. This dual infection may occur during the primary infection period, before the immune response is fully developed, or it may occur as a superinfection with a new viral strain after the initial strain has established a chronic infection. Both superinfection and recombination have the potential to complicate efforts to develop vaccines, and reinfection with a drug-resistant virus could jeopardize treatment [14].

Superinfection with a new strain may make recombination between the original and new strains possible. Although recombination following superinfection has been postulated, it has not been observed in individuals [15]. Previous studies have identified fully formed recombinants in patients, but not recombination between the non-recombinant first and superinfecting strains occurring in the same individual [1–11]. Some individuals have been infected by recognized circulating recombinant forms, which were transmitted in primary infection [1–4,10,11]; in these cases, the recombination event presumably occurred in a previously infected patient [2,10]. A small number of unique recombinants have also been detected in the setting of primary infection [1–11]. With increasing recognition of recombinant strains globally, it was unclear whether recombination resulted from superinfection of chronically infected individuals. The distinct HIV-1 subtypes or clades seen in different regions of the world differ from one another by as much as 30% in the envelope gene (env) and up to 15% in the core proteins [2]. Strains classified as different subtypes are genetically quite distinct, making it relatively easy to detect superinfection and recombination. To determine whether recombination has occurred at any site in a viral genome, it is best to analyze the complete genomic sequence of the virus. Detection of superinfection and recombination between strains of the same subtype can be challenging [2] because of the difficulty of distinguishing different viral species of the same subtype from variation within a strain as a result of evolution.

Instances of cross-clade and intraclade coinfection [7,8,16–20] and superinfection have been previously reported, particularly during and soon after primary infection and in the setting of treatment interruptions of chronic infections [15,21–24]. The determination of superinfection in two of these cases was aided by epidemiological and immunological investigation [22,23]. The possibility of dual transmission during the primary infection period, however, was not completely excluded by highly sensitive, virological analyses in these and other studies [11,14,21–23,25]. It has been unclear whether recombination occurs only in the primary infection period [1–10] or can result from superinfection during untreated, chronic infection.

The present study searches for evidence of superinfection and recombination in Africa, where multiple HIV-1 subtypes exist, by examining serial blood samples from women in Nairobi's Pumwani sex worker cohort. The dominant HIV-1 subtype in Kenya is clade A HIV-1, which accounts for ∼70% of HIV-1 infections, the remainder consisting of clades D (∼20%), C, and several minor species [2]. The women in this cohort, like most infected individuals worldwide, have never received treatment and it was interesting to determine whether such seropositive, chronically infected individuals are susceptible to superinfection with a new strain and whether the superinfection could lead to recombination. Highly exposed persons, such as the women in the Pumwani cohort, may be particularly vulnerable to reinfection because their partners expose them to a range of different viral strains; this makes recombination more likely to be detected in this group. Full-length HIV-1 RNA sequences from seven long-term survivors have been analyzed for the appearance of new subtypes and recombinants.

Back to Top | Article Outline

Methods

Clinical study subjects

The subjects studied were women enrolled in the Pumwani sex worker cohort. This cohort was established in 1985 by the Universities of Nairobi and Manitoba to study HIV-1 and other sexually transmitted diseases. The cohort currently comprises over 1850 women who are commercial sex workers in a Nairobi slum area. They have never been treated with antiretroviral drugs. The research program was approved by the National Ethical and Scientific Review Committee of Kenyatta National Hospital, the University of Manitoba Use of Human Subjects in Research Review Committee, and the NY State Department of Health Institutional Review Board.

Within the cohort, there are several subgroups of HIV-1-infected individuals, including rapid progressors, long-term non-progressors, and long-term survivors. Long-term survivors are defined as surviving with HIV-1 infection for at least 10 years.

The women were evaluated clinically at approximately 6-month intervals. Lymphocyte subsets were determined using a FACscan flow cytometer (Becton Dickson, San Jose, California, USA). Plasma viral loads were determined using Amplicor assay (Roche Molecular Systems, Branchburg, New Jersey, USA).

Back to Top | Article Outline
HIV-1 virus isolation and amplification

HIV-1 virions were isolated from plasma. The plasma was clarified by centrifugation for 10 min at 400 × g at room temperature and then transferred to a sterile, siliconized 1.5 ml microcentrifuge tube; virions were collected by centrifugation at 18 500 × g for 90 min at 10°C. Virion-associated RNA was extracted from the virus using reagents from RNAgents Total RNA Isolation System Kit (Promega, Madison, Wisconsin, USA).

The HIV-1 RNA genome was amplified by long reverse transcription (RT) polymerase chain reaction (PCR) [26–29]. The RT reaction was carried out in a 20 μl mixture containing extracted HIV-1 viral RNA (5 μl), 1 U RNase inhibitor (PerkinELMER, Boston, Massachusetts, USA), 1.0 mmol/l of each deoxynucleoside trisphosphate (dNTP), 2.5 U (RNase H) murine leukemia virus reverse transcriptase (PerkinELMER), 0.1 μg bovine serum albumin, 10 mmol/l Tris-HCL (pH 8.3), 8 mmol/l MgCl2, 50 mmol/l KCl, 10 mmol/l DTT, and 2.5 μmol/l oligo (dT) primer. The reaction mixture was incubated for 60 min at 42°C and then at 95°C for 5 min.

The reverse transcribed HIV-1 RNA genome was amplified by long RT PCR using rTth XL DNA polymerase (PerkinELMER). Specific primers were used with primer sequences listed in Table 1. When the HIV-1 RNA load is high, the entire genome can be amplified in two fragments. The 3′ part of the genome (∼ 5 kb) was amplified using F4650 and R9626; the 5′ part (4.5 kb) was amplified using AF2 and R5090 primers. For samples with moderate or low viral titer, genomes were amplified as four overlapping fragments by using nested PCR. The primers for the first PCR were F4650 and R9626; for the second PCR, primers F4956 and R9173 or F7695 and R9626 were employed (Table 1). The middle part of the viral genome (3 kb) was amplified using primers F2018 and R5220 for the first PCR and F2042 and R5090 for the second PCR. The 5′ end of the genome (1.5 kb) was amplified by using nested PCR, with primers AF 2 and AR 1603 employed for the first PCR and AF 6 and AR 1539 for the second PCR. Each cycle of PCR consisted of a 15 s denaturation step at 94°C and an annealing and elongation step of 3–4.5 min (1 min/kb) at 60°C. After 40 PCR cycles were completed, the samples were extended for an additional 10 min at 72°C to ensure that the PCR products were full length. The PCR products were checked for size using 0.8% SeaKem GTG agarose gel (FMC, Rockland, Maine, USA) and ethidium bromide staining.

Table 1
Table 1
Image Tools

Although effective in amplifying molecules of RNA, RT-PCR carries potential pitfalls of recombination between molecules and underestimates sequence diversity. To decrease the chance of underestimating diversity, multiple RT reactions were performed on limiting dilutions of RNA, followed by multiple PCR on complimentary DNA (cDNA) from each RT reaction. The DNA was sequenced from the dilution yielding PCR products in only half of the reactions. To minimize the potential for PCR-related recombination during long RT-PCR, the reaction conditions were controlled using the methods described in our previous studies [26–29].

Back to Top | Article Outline
Sequencing and sequence analysis of HIV-1 genome

After verification of fragment size by gel electrophoresis, the PCR products were purified using PCR Select Spin Columns (5′Prime to 3′Prime, Inc. Boulder, Colorado, USA). The purified DNA fragments were then quantified and analyzed directly by DNA sequencing. PCR fragments were fully sequenced on both strands by using fluorescent dye terminators and an Applied Biosystems DNA sequencer (Applied Biosystems, Foster City, California, USA). Long overlapping DNA sequences were obtained and those with the highest degree of similarity in the overlaps were assembled using Sequencher (Ann Arbor, Michigan, USA) and BioEdit programs. Sequence ambiguities were checked and resolved manually.

Back to Top | Article Outline
Computational analysis

Full-length HIV-1 sequences derived from plasma viral RNA were aligned and subjected to computational analysis. A BLAST search was performed on all sequences and did not show any undue similarity to other strains [2]. Phylogenetic trees were constructed using neighbor-joining trees based on Kimura's two-parametric distance estimates. HIV-1 subtypes were determined by using phylogenetic analysis, distance plotting, and bootscanning; the latter two with the help of SimPlot [5]. Recombination was determined by distance plotting, followed by bootscanning and tree construction using the recombinant fragments.

Back to Top | Article Outline
Heteroduplex tracking assay

The frequencies of genetic HIV-1 variants isolated from ML170, the patient under study, at each time point were compared using a non-radioactive adaptation of the DNA heteroduplex tracking assay [30]. To amplify a 288 bp fragment spanning the V1–V2 coding region of env, RT-PCR was performed using the following PCR primer pair: 5′-ATGGGATCAAA GCCTAAAGCCATGTG-3′ (6556F) and 5′-CTTTG GACAGGCCTGTGTAATGGGTGAGG-3′ (6844R). Each RT-PCR was repeated to verify representative sampling of the RNA templates. Viruses from two additional patients enrolled in the Nairobi sex worker cohort were included as local clade-specific controls. Their env sequences and subtypes were determined as described above. The virus env sequences are clade A and clade C specific and were given the names Nairobi A and Nairobi C, respectively.

A fluorescent probe was generated by PCR of cloned HIV-1 DNA derived from ML170 at each time point (1986, 1995, 1997). Cloned HIV-1 was used to ensure that each probe represented a single uniform viral variant; for each time point, nucleotide sequences were determined, compared with previously obtained sequence from patient ML170, and the clade was ascertained genotypically. For the PCR reaction, a 5′-fluorescein-labelled forward primer (6556F; Invitrogen, Carlsbad, California, USA) and an unlabelled reverse primer (6844R) were used. Heteroduplex formation was carried out using fluorescein-labelled probe mixed with a 10-fold excess of unlabelled target DNA. The resulting DNA heteroduplex molecules were electrophoresed through 10% non-denaturing polyacrylamide gels, which were scanned on a FluorImager 595 (Molecular Dynamics, Piscataway, New Jersey, USA).

Back to Top | Article Outline

Results

Seven subjects in the Nairobi female sex worker cohort were chosen for study because they were long-term survivors, infected at least 10 years, and had detectable HIV-1 RNA plasma viral loads ranging from 2300 to 1 430 000 copies/ml. Because the median time from HIV-1 infection to development of AIDS in this cohort of untreated female sex workers is 4.4 years [31], survival of more than 10 years is remarkable. Complete HIV-1 genomic sequences were determined from plasma viral RNA from all seven subjects. Three patients demonstrated HIV-1 genomes in 1997 that were intersubtype recombinants. For two of these three, the same recombinants were detected in 1986. One of these subjects, however, ML170, had evidence of recombination and superinfection.

Subject ML170 enrolled in the Pumwani female sex worker cohort in Nairobi, Kenya in 1985, when she was 22 years old and had already been a prostitute for 4 years. At the time of enrollment, February 1985, ML170 was found to be HIV-1 seropositive. She was followed at the Pumwani sex worker clinic at least every 6 months, where she reported having an average of two to three clients per day and using condoms less than 5% of the time. Most of her clinic visits were occasioned by symptoms of sexually transmitted infections, including pelvic inflammatory disease, genital herpes, and genital warts. In April, 1992, she had an acute febrile illness with chills, the only documented febrile illness in her medical records from 1985 to 1997. Her CD4 lymphocyte count plummeted from 794 × 106 cells/l in March 1991 to 136 × 106 cells/l in April 1992, the time of her acute febrile illness, and it remained < 100 × 106 cells/l from October 1992 until 1998. The HIV-1 RNA load in plasma rose from 2300 copies/ml in 1986 to 87 000 in 1997 (Fig. 1). After maintaining a stable weight of 65 kg annually from 1988 to 1993, she began to lose weight in 1994 and continued to lose yearly until her death. Her genotypes for CCR5 and CCR2 were wild type. ML170 never received antiretroviral therapy and she died in 1998 from tuberculosis and cryptococcal infection complicating her HIV-1 infection.

Fig. 1
Fig. 1
Image Tools

Complete HIV-1 RNA sequences were obtained from subject ML170's plasma in November 1986, when she had been infected for at least 21 months, and in 1995 and 1997 (GenBank accession numbers AF539404–6). Full-length viral genomes were sequenced directly, then aligned and subjected to computational analysis. A BLAST search revealed no evidence of contamination. Recombination was determined by computational analyses of the serial sequences. The entire genome obtained in 1986 was determined to be subtype A, shown in the bootscan in Fig. 2a. In 1995 and 1997, however, the sequences were subtype A/C recombinants (Fig. 2b). Comparison of full-length sequences from 1986, 1995, and 1997 with sequences from the Los Alamos HIV Database using SimPlots demonstrated that the A regions of the 1995 and 1997 A/C recombinants were derived from the subtype A sequence present in 1986 in the same individual (Fig. 3).

Fig. 2
Fig. 2
Image Tools
Fig. 3
Fig. 3
Image Tools

To determine whether subtype C sequences were present as minor species in 1986, heteroduplex tracking assays were performed. These assays are capable of detecting rare recombinant species making up as little as 0.2% of the viral population [30], a degree of sensitivity empirically confirmed in our own laboratory (data not shown). DNA fragments from ML170's env genes obtained in 1986, 1995, and 1997 were annealed with subtype-specific env probes. The subtype C sequences were not detectable in the 1986 sample (Fig. 4).

Fig. 4
Fig. 4
Image Tools

These data confirm the interpretation that this chronically infected woman was superinfected with a new subtype C virus at some time after 1986, with subsequent recombination between her subtype A and C strains.

Back to Top | Article Outline

Discussion

With frequent recombination between distinct viral strains now recognized in the HIV-1 epidemic [2,11] and reports of superinfection in the literature [21–24], it has been hypothesized that recombination is likely to occur following superinfection [15]. Recombination, however, was not found in the cases of superinfection recently reported [21–24]. It has been unclear whether the viral recombination now recognized globally arises only during primary infection or can result from superinfection of an untreated chronically infected individual.

We observed HIV-1 recombination following superinfection of a highly exposed woman from Nairobi, Kenya. The woman was chronically infected at the time of superinfection and had never received antiretroviral therapy. We examined blood plasma using complete viral genomic sequencing, computational and phylogenetic analyses including SimPlots, and heteroduplex tracking assays, a highly sensitive technique to detect minor species.

We used these techniques to the limit of detection to document superinfection with resulting recombination between the original 1986 HIV-1 subtype A and the superinfecting subtype C strains. The subtype A/C recombinant replaced the 1986 subtype A virus of this patient. Other studies in the literature have also documented replacement of one strain by another in coinfected patients [22,23]. Because of an insufficient number of useful specimens, we were unable to detect the superinfecting subtype C virus prior to recombination. Similarly, we were unable to study ML170's immunological responses or viral loads in greater detail because of a lack of samples. Although our data are highly suggestive of superinfection, ultimate proof of superinfection, as opposed to dual infection, has not been obtained in this or any of the previous reports.

This report adds to the growing literature documenting superinfection [21–24]. It is unclear what effect, if any, superinfection may have on disease progression. In the case described here, superinfection may have been associated with the abrupt decline in the CD4 T cell count, which did not rise again. Considering ML170's frequent HIV-1 exposure, the rapid decline in her CD4 T cell count between 1991 and 1992, and her steady weight loss beginning in 1994, it is possible that superinfection occurred during the period of her febrile illness in 1992. Superinfection may be associated with immunodeficiency and disease progression, particularly if it is a consequence of an escape from immune control [22]. It is unclear whether superinfection may result from the loss of immunity, lead to immune deficiency, or both. In addition, superinfection could result in the acquisition of drug-resistant HIV-1 [14].

The frequency of superinfection and recombination has not been studied in a systematic way and needs to be investigated in a variety of populations. Cases of superinfection and recombination may escape detection when the circulating strains in a community are all of the same clade and the analyses focus on fragments of the viral genome rather than the complete HIV-1 sequence. Highly exposed individuals may be at higher risk of superinfection and resulting recombination than those with limited exposures. It will be of interest to determine the frequency of superinfection in highly exposed populations to address whether those individuals who do not become reinfected are resistant to superinfection. Such studies may help to evaluate the correlates of protection.

The case described here demonstrates that superinfection during chronic infection may play a significant role in the formation of recombinants between HIV-1 strains. This finding helps to explain the rising prevalence of recombinant HIV-1 in the world [2,11,12]. Furthermore, it illustrates that chronic infection with one strain may not provide protection against challenge from another. Recombination resulting from superinfection with diverse strains may pose problems for eliciting the broad immune responses necessary for an effective vaccine.

Back to Top | Article Outline

Acknowledgements

We thank Kimdar Sherefa Kemal for helpful discussions, Chih-Hsiung Chen for technical assistance, and Suzanne Beck for manuscript preparation. We thank Tim Moran, Matt Shudt, and the Wadsworth Center Molecular Genetics Core for oligonucleotide synthesis and DNA sequence analysis.

Sponsorship: This project was funded by the MRC and NIH grant RO1-AI42555.

Back to Top | Article Outline

References

1. Gao F, Robertson DL, Carruthers CD, Morrison SG, Jian B, Chen Y, et al. A comprehensive panel of near full length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998, 72:5680–5698.

2. Kuiken C, Foley B, Hahn B, Korber, B, McCutchan F, Marx P, et al. HIV Sequence Compendium 2000. Los Alamos, NM: Los Alamos National Laboratory; 2000.

3. Dowling WE, Kim B, Mason CJ, Wasunna KM, Alam U, Elson L, et al. Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS 2002, 16:1809–1820.

4. Sabino EC, Shpaer EG, Morgado MG, Korber BT, Diaz RS, Bongertz V, et al. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol 1994, 68:6340–6346.

5. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999, 73:152–160.

6. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature 1995, 374:124–126.

7. Salminen MO, Carr JK, Robertson DL, Hegerich P, Gotte D, Koch C, et al. Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol 1997, 71:2647–2655.

8. Diaz RS, Sabino EC, Mayer A, Mosley JW, Busch MP. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol 1995, 69:3273–3281.

9. Kampinga GA, Simonon A, van de Perre P, Karita E, Msellati P, Goudsmit J. Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 1997, 227:63–76.

10. Thomson MM, Perez-Alvarez L, Najera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002, 2:461–471.

11. Najera R, Delgado E, Perez-Alvarez L, Thomas MM. Genetic recombination and its role in the development of the HIV-1 pandemic. AIDS 2002, 16:S3–S16.

12. Malim MH, Emerman M. HIV-1 sequence variation: drift, shift, and attenuation. Cell 2001, 104:469–472.

13. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, Fischer U, et al. Recombination: multiply infected spleen cells in HIV patients. Nature 2002, 418:144.

14. Levy JA. Is HIV superinfection worrisome? Lancet 2003, 361:98–99.

15. Goulder PJ, Walker BD. HIV-1 superinfection-a word of caution. N Engl J Med 2002, 347:756–758.

16. Zhu T, Wang N, Carr A, Wolinsky S, Ho DD. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. J Virol 1995, 69:1324–1327.

17. Artenstein AW, VanCott TC, Mascola JR, Carr JK, Hegerich PA, Gaywee J, et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis 1995, 171:805–810.

18. Sala M, Pelletier E, Wain-Hobson S. HIV-1 gp120 sequences from a doubly infected drug user. AIDS Res Hum Retroviruses 1995, 11:653–655.

19. Janini LM, Tanuri A, Schechter M, Peralta JM, Vicente AC, Dela Torre N, et al. Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. J Infect Dis 1998, 177:227–231.

20. Iversen AK, Learn GH, Fugger L, Gerstoft J, Mullins JI, Skinhoj P. Presence of multiple HIV subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women. J Acquir Immune Defic Syndr 1999, 22:325–332.

21. Ramos A, Hu DJ, Nguyen L, Phan KO, Vanichseni S, Promadej N, et al. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002, 76:7444–7452.

22. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002, 420:434–439.

23. Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, et al. A patient with HIV-1 superinfection. N Engl J Med 2002, 347:731–736.

24. Koelsch KK, Smith DM, Little SJ, Ignacio CC, Macaranas TA, Leigh Brown AJ, et al. Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus. AIDS 2003, 17:F11–F16.

25. McMichael AJ, Rowland-Jones SL. HIV: bad news for stop-start therapy? Nature 2002, 420:371–373.

26. Fang G, Weiser B, Visosky A, Moran T, Burger H. PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA. Nat Med 1999, 5:239–242.

27. Fang G, Zhu G, Burger H, Keithly JS, Weiser B. Minimizing DNA recombination during long RT-PCR. J Virol Meth 1998, 76: 139–148.

28. Fang G, Weiser B, Visosky AA, Townsend L, Burger H. Molecular cloning of full-length HIV-1 genomes directly from plasma viral RNA. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:352–357.

29. Fang G, Burger H, Chappey C, Rowland-Jones SL, Visosky A, Chen CH, et al. Analysis of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1. AIDS Res Hum Retroviruses 2001, 17:1395–1404.

30. Delwart EL, Gordon CJ. Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis. Methods 1997, 12:348–354.

31. Anzala AO, Nagelkerke N, Bwayo JJ, Holton D, Moses S, Ngugi E, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995, 171:686–689.

Cited By:

This article has been cited 65 time(s).

Lancet Infectious Diseases
Frequency and implications of HIV superinfection
Redd, AD; Quinn, TC; Tobian, AAR
Lancet Infectious Diseases, 13(7): 622-628.
10.1016/S1473-3099(13)70066-5
CrossRef
AIDS Research and Human Retroviruses
Dynamics of HIV Type 1 Recombination Following Superinfection
Koning, FA; Badhan, A; Shaw, S; Fisher, M; Mbisa, JL; Cane, PA
AIDS Research and Human Retroviruses, 29(6): 963-970.
10.1089/aid.2013.0009
CrossRef
Journal of Experimental Medicine
Immune-driven recombination and loss of control after HIV superinfection
Streeck, H; Li, B; Poon, AFY; Schneidewind, A; Gladden, AD; Power, KA; Daskalakis, D; Bazner, S; Zuniga, R; Brander, C; Rosenberg, ES; Frost, SDW; Altfeld, M; Allen, TM
Journal of Experimental Medicine, 205(8): 1789-1796.
10.1084/jem.20080281
CrossRef
Plos Computational Biology
Identifying the Important HIV-1 Recombination Breakpoints
Archer, J; Pinney, JW; Fan, J; Simon-Loriere, E; Arts, EJ; Negroni, M; Robertson, DL
Plos Computational Biology, 4(9): -.
ARTN e1000178
CrossRef
AIDS Research and Human Retroviruses
Polymorphism, Recombination, and Mutations in HIV Type 1 gag-Infecting Peruvian Male Sex Workers
Yabar, CA; Salvatierra, J; Quijano, E
AIDS Research and Human Retroviruses, 24(): 1405-1413.
10.1089/aid.2008.0130
CrossRef
Antiviral Therapy
HIV-1 subtypes and response to combination antiretroviral therapy in Europe
Bannister, WP; Ruiz, L; Loveday, C; Vella, S; Zilmer, K; Kjaer, J; Knysz, B; Phillips, AN; Mocroft, A; Lundgren, JD
Antiviral Therapy, 11(6): 707-715.

AIDS Research and Human Retroviruses
Genetic diversity of HIV-1 non-B strains in Sicily: Evidence of intersubtype recombinants by sequence analysis of gag, pol, and env genes
Tramuto, F; Bonura, F; Perna, AM; Mancuso, S; Firenze, A; Romano, N; Vitale, F
AIDS Research and Human Retroviruses, 23(9): 1131-1138.
10.1089/aid.2007.0031
CrossRef
Retrovirology
HIV-1 sequence evolution in vivo after superinfection with three viral strains
Kozaczynska, K; Cornelissen, M; Reiss, P; Zorgdrager, F; van der Kuyl, AC
Retrovirology, 4(): -.
ARTN 59
CrossRef
AIDS Research and Human Retroviruses
Structural basis for coreceptor selectivity by the HIV type 1 V3 loop
Cardozo, T; Kimura, T; Philpott, S; Weiser, B; Burger, H; Zolla-Pazner, S
AIDS Research and Human Retroviruses, 23(3): 415-426.
10.1089/aid.2006.0130
CrossRef
AIDS Research and Human Retroviruses
Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa
Toni, T; Adje-Toure, C; Vidal, N; Minga, A; Huet, C; Borger, MY; Recordon-Pinson, P; Masquelier, B; Nolan, M; Nkengasong, J; Fleury, HJ; Delaporte, E; Peeters, M
AIDS Research and Human Retroviruses, 21(7): 667-672.

Clinical Infectious Diseases
HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: A case report
Gottlieb, GS; Nickle, DC; Jensen, MA; Wong, KG; Kaslow, RA; Shepherd, JC; Margolick, JB; Mullins, JI
Clinical Infectious Diseases, 45(4): 501-509.
10.1086/520024
CrossRef
Sexual Health
Incidence of putative HIV superinfection and sexual practices among HIV-infected men who have sex with men
Sidat, MM; Mijch, AM; Lewin, SR; Hoy, JF; Hocking, J; Fairley, CK
Sexual Health, 5(1): 61-67.
10.1071/SH07041
CrossRef
Journal of Computational Biology
RB-Finder: An improved distance-based sliding window method to detect recombination breakpoints
Lee, WH; Sung, WK
Journal of Computational Biology, 15(7): 881-898.
10.1089/cmb.2007.0154
CrossRef
Journal of General Virology
Readily acquired secondary infections of human and simian immunodeficiency viruses following single intravenous exposure in non-human primates
ten Haaft, P; Verschoor, EJ; Verstrepen, B; Niphuis, H; Dubbes, R; Koornstra, W; Bogers, W; Rosenwirth, B; Heeney, JL
Journal of General Virology, 85(): 3735-3745.
10.1099/vir.0.80223-0
CrossRef
Indian Journal of Medical Research
Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development
Lal, RB; Chakrabarti, S; Yang, CF
Indian Journal of Medical Research, 121(4): 287-314.

Bioinformatics
Stepwise detection of recombination breakpoints in sequence alignments
Graham, J; McNeney, B; Seillier-Moiseiwitsch, F
Bioinformatics, 21(5): 589-595.
10.1093/bioinformatics/bti040
CrossRef
Biochemistry
A complementary single-stranded docking site is required for enhancement of strand exchange by human immunodeficiency virus nucleocapsid protein on substrates that model viral recombination
Heath, MJ; DeStefano, JJ
Biochemistry, 44(): 3915-3925.
10.1021/bi0477945
CrossRef
Plos Pathogens
Molecular Mechanisms of Recombination Restriction in the Envelope Gene of the Human Immunodeficiency Virus
Simon-Loriere, E; Galetto, R; Hamoudi, M; Archer, J; Lefeuvre, P; Martin, DP; Robertson, DL; Negroni, M
Plos Pathogens, 5(5): -.
ARTN e1000418
CrossRef
Journal of Infectious Diseases
HIV-1 drug resistance in variants from the female genital tract and plasma
Kemal, KS; Burger, H; Mayers, D; Anastos, K; Foley, B; Kitchen, C; Huggins, P; Schroeder, T; Picchio, G; Back, S; Gao, W; Meyer, WA; Weiser, B
Journal of Infectious Diseases, 195(4): 535-545.

AIDS Research and Human Retroviruses
Short Communication: HIV Type 1 Genetic Diversity among Tea Plantation Workers in Kericho, Kenya
Arroyo, MA; Sateren, WB; Foglia, G; Kibaya, R; Langat, L; Wasunna, M; Bautista, CT; Scott, PT; Shaffer, DN; Robb, ML; Michael, NL; Birx, DL; McCutchan, FE
AIDS Research and Human Retroviruses, 25(): 1061-1064.
10.1089/aid.2009.0092
CrossRef
Journal of Virology
Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: Compartmentalization and intrapatient recombination
Philpott, S; Burger, H; Tsoukas, C; Foley, B; Anastos, K; Kitchen, C; Weiser, B
Journal of Virology, 79(1): 353-363.
10.1128/JVI.79.1.353-363.2005
CrossRef
Microbiology and Molecular Biology Reviews
The Remarkable Frequency of Human Immunodeficiency Virus Type 1 Genetic Recombination
Onafuwa-Nuga, A; Telesnitsky, A
Microbiology and Molecular Biology Reviews, 73(3): 451-+.
10.1128/MMBR.00012-09
CrossRef
Virology
Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy
Shi, B; Kitchen, C; Weiser, B; Mayers, D; Foley, B; Kemal, K; Anastos, K; Suchard, M; Parker, M; Brunner, C; Burger, H
Virology, 404(1): 5-20.
10.1016/j.virol.2010.04.008
CrossRef
AIDS Research and Human Retroviruses
Construction of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C recombinant virus
Shi, BS; Philpott, SM; Weiser, B; Kuiken, C; Brunner, C; Fang, GW; Fowke, KR; Plummer, FA; Rowland-Jones, S; Bwayo, J; Anzala, AO; Kimani, J; Kaul, R; Burger, H
AIDS Research and Human Retroviruses, 20(9): 1015-1018.

AIDS Research and Human Retroviruses
Characterization of intersubtype recombinant HIV type 1 genomes using a nonradioactive heteroduplex tracking assay
Schroeder, TL; Burger, H; Weiser, B; Bengualid, V; Kimani, J; Anzala, AO; Parker, MM; Lamson, D; Philpott, SM
AIDS Research and Human Retroviruses, 21(4): 314-318.

Journal of Virology
Selective escape from CD8(+) T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution
Allen, TM; Altfeld, M; Geer, SC; Kalife, ET; Moore, C; O'Sullivan, KM; DeSouza, I; Feeney, ME; Eldridge, RL; Maier, EL; Kaufmann, DE; Lahaie, MP; Reyor, L; Tanzi, G; Johnston, MN; Brander, C; Draenert, R; Rockstroh, JK; Jessen, H; Rosenberg, ES; Mallal, SA; Walker, BD
Journal of Virology, 79(): 13239-13249.
10.1128/JVI.79.21.13239-13249.2005
CrossRef
Journal of Infectious Diseases
Coinfection and superinfection in patients with long-term, nonprogressive HIV-1 disease
Casado, C; Pernas, M; Alvaro, T; Sandonis, V; Garcia, S; Rodriguez, C; del Romero, J; Grau, E; Ruiz, L; Lopez-Galindez, C
Journal of Infectious Diseases, 196(6): 895-899.
10.1086/520885
CrossRef
Journal of Neurovirology
The spread of HIV in Africa
Mokili, J; Korber, B
Journal of Neurovirology, 11(): 66-75.
10.1080/13550280590923008
CrossRef
AIDS Reviews
Mechanistic features of recombination in HIV
Galetto, R; Negroni, M
AIDS Reviews, 7(2): 92-102.

Journal of Virology
Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype
Chohan, B; Lavreys, L; Rainwater, SMJ; Overbaugh, J
Journal of Virology, 79(): 10701-10708.
10.1128/JVI.79.16.10701-10708.2005
CrossRef
Virology Journal
Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection
Bandawe, GP; Martin, DP; Treurnicht, F; Mlisana, K; Karim, SSA; Williamson, C
Virology Journal, 5(): -.
ARTN 141
CrossRef
Retrovirology
Retroviral superinfection resistance
Nethe, M; Berkhout, B; van der Kuyl, AC
Retrovirology, 2(): -.
ARTN 52
CrossRef
Journal of Neurovirology
Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence
Afkhami-Goli, A; Liu, SH; Zhu, Y; Antony, JM; Arab, H; Power, C
Journal of Neurovirology, 15(2): 139-152.
10.1080/13550280802534763
CrossRef
AIDS Research and Human Retroviruses
Difficulties in classifying A/G recombinants: Methodological problems or genetic variability?
Brindicci, G; Punzi, G; Lagioia, A; Lo Caputo, S; Ladisa, N; Di Nicuolo, G; Saracino, A; Angarano, G; Monno, L
AIDS Research and Human Retroviruses, 23(6): 840-846.
10.1089/aid.2006.0205
CrossRef
Journal of Clinical Virology
HIV-1 elite controllers: Beware of super-infections
Clerc, O; Colombo, S; Yerly, S; Telenti, A; Cavassini, M
Journal of Clinical Virology, 47(4): 376-378.
10.1016/j.jcv.2010.01.013
CrossRef
Journal of Infectious Diseases
HIV superinfection
Smith, DM; Richman, DD; Little, SJ
Journal of Infectious Diseases, 192(3): 438-444.

AIDS
HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania
Arroyo, MA; Hoelscher, M; Sateren, W; Samky, E; Maboko, L; Hoffmann, O; Kijak, G; Robb, M; Birx, DL; McCutchan, FE
AIDS, 19(): 1517-1524.

AIDS Reviews
Molecular epidemiology of HIV-1 variants in the global aids pandemic: an update
Thomson, MM; Najera, R
AIDS Reviews, 7(4): 210-224.

Molecular Phylogenetics and Evolution
An exploratory algorithm to identify intra-host recombinant viral sequences
Salemi, M; Gray, RR; Goodenow, MM
Molecular Phylogenetics and Evolution, 49(2): 618-628.
10.1016/j.ympev.2008.08.017
CrossRef
AIDS Research and Human Retroviruses
Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants
Land, AM; Ball, TB; Luo, M; Rutherford, J; Sarna, C; Wachihi, C; Kimani, J; Plummer, FA
AIDS Research and Human Retroviruses, 24(6): 865-872.
10.1089/aid.2007.0200
CrossRef
Journal of Virology
Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate
Yeh, WW; Jaru-Ampornpan, P; Nevidomskyte, D; Asmal, M; Rao, SS; Buzby, AP; Montefiori, DC; Korber, BT; Letvin, NL
Journal of Virology, 83(6): 2686-2696.
10.1128/JVI.02237-08
CrossRef
Journal of Infectious Diseases
The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient
Blick, G; Kagan, RM; Coakley, E; Petropoulos, C; Maroldo, L; Greiger-Zanlungo, P; Gretz, S; Garton, T
Journal of Infectious Diseases, 195(9): 1250-1259.
10.1086/512240
CrossRef
Retrovirology
High genetic variability of HIV-1 in female sex workers from Argentina
Pando, MA; Eyzaguirre, LM; Carrion, G; Montano, SM; Sanchez, JL; Carr, JK; Avila, MM
Retrovirology, 4(): -.
ARTN 58
CrossRef
Journal of Virology
Precise identification of endogenous proviruses of NFS/N mice participating in recombination with Moloney ecotropic murine leukemia virus (MuLV) to generate polytropic MuLVs
Alamgir, ASM; Owens, N; Lavignon, M; Malik, F; Evans, LH
Journal of Virology, 79(8): 4664-4671.
10.1128/JVI.79.8.4664-4671.2005
CrossRef
Journal of Biological Chemistry
Dissection of a circumscribed recombination hot spot in HIV-1 after a single infectious cycle
Galetto, R; Giacomoni, VR; Veron, M; Negroni, M
Journal of Biological Chemistry, 281(5): 2711-2720.
10.1074/jbc.M505457200
CrossRef
Journal of Infectious Diseases
Long-term survivors in Nairobi: Complete HIV-1 RNA sequences and immunogenetic associations
Fang, GW; Kuiken, C; Weiser, B; Rowland-Jones, S; Plummer, F; Chen, CH; Kaul, R; Anzala, AO; Bwayo, J; Kimani, J; Philpott, SM; Kitchen, C; Sinsheimer, JS; Gaschen, B; Lang, D; Shi, BS; Kemal, KS; Rostron, T; Brunner, C; Beddows, S; Sattenau, Q; Paxinos, E; Oyugi, J; Burger, H
Journal of Infectious Diseases, 190(4): 697-701.

Journal of Virology
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions
Joos, B; Trkola, A; Fischer, M; Kuster, H; Rusert, P; Leemann, C; Boni, R; Oxenius, A; Price, DA; Phillips, RE; Wong, JK; Hirschel, B; Weber, R; Gunthard, HF
Journal of Virology, 79(): 9026-9037.
10.1128/JVI.79.14.9026-9037.2005
CrossRef
AIDS
Understanding the diversification of HIV-1 groups M and O
Archer, J; Robertson, DL
AIDS, 21(): 1693-1700.

Mathematical Biosciences
Superinfection with a heterologous HIV strain per se does not lead to faster progression
Fung, ICH; Gambhir, M; van Sighem, A; de Wolf, F; Garnett, GP
Mathematical Biosciences, 224(1): 1-9.
10.1016/j.mbs.2009.11.007
CrossRef
Clinical Infectious Diseases
Absence of HIV-1 Superinfection 1 Year after Infection between 1985 and 1997 Coincides with a Reduction in Sexual Risk Behavior in the Seroincident Amsterdam Cohort of Homosexual Men
Rachinger, A; Stolte, IG; van de Ven, TD; Burger, JA; Prins, M; Schuitemaker, H; van 't Wout, AB
Clinical Infectious Diseases, 50(9): 1309-1315.
10.1086/651687
CrossRef
Journal of Biological Chemistry
Mechanistic analysis of pause site-dependent and -independent recombinogenic strand transfer from structurally diverse regions of the HIV genome
Derebail, SS; DeStefano, JJ
Journal of Biological Chemistry, 279(): 47446-47454.
10.1074/jbc.M408927200
CrossRef
Plos One
Multiplex RT-PCR Amplification of HIV Genes to Create a Completely Autologous DC-Based Immunotherapy for the Treatment of HIV Infection
Tcherepanova, I; Harris, J; Starr, A; Cleveland, J; Ketteringham, H; Calderhead, D; Horvatinovich, J; Healey, D; Nicolette, CA
Plos One, 3(1): -.
ARTN e1489
CrossRef
Journal of Virology
Retroviral recombination in vivo: Viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239 Delta vpx/Delta vpr and SIVmac239 Delta nef
Kim, EY; Busch, M; Abel, K; Fritts, L; Bustamante, P; Stanton, J; Lu, D; Wu, S; Glowczwskie, J; Rourke, T; Bogdan, D; Piatak, M; Lifson, JD; Desrosiers, RC; Wolinsky, S; Miller, CJ
Journal of Virology, 79(8): 4886-4895.
10.1128/JVI.79.8.4886-4895.2005
CrossRef
Infections in Medicine
Sexual transmission of HIV-1: Preexposure and postexposure prophylaxis
Nielsen, K
Infections in Medicine, 22(4): 175-+.

Proceedings of the 7Th Ieee International Symposium on Bioinformatics and Bioengineering, Vols I and II
Hot and cold: Spatial fluctuation in HIV-1 recombination rates
Rajaram, ML; Minin, VN; Suchard, MA; Dorman, KS
Proceedings of the 7Th Ieee International Symposium on Bioinformatics and Bioengineering, Vols I and II, (): 707-714.

Retrovirology
Multiple-infection and recombination in HIV-1 within a longitudinal cohort of women
Templeton, AR; Kramer, MG; Jarvis, J; Kowalski, J; Gange, S; Schneider, MF; Shao, QJ; Zhang, GW; Yeh, MF; Tsai, HL; Zhang, H; Markham, RB
Retrovirology, 6(): -.
ARTN 54
CrossRef
Journal of Virological Methods
Evaluation of pre-screening methods for the identification of HIV-1 superinfection
Rachinger, A; van de Ven, TD; Burger, JA; Schuitemaker, H; van't Wout, AB
Journal of Virological Methods, 165(2): 311-317.
10.1016/j.jviromet.2010.02.016
CrossRef
Ecology Letters
Multiple infections and the evolution of virulence
Alizon, S; de Roode, JC; Michalakis, Y
Ecology Letters, 16(4): 556-567.
10.1111/ele.12076
CrossRef
AIDS Research and Human Retroviruses
New Subtypes and Genetic Recombination in HIV Type 1-Infecting Patients with Highly Active Antiretroviral Therapy in Peru (2008-2010)
Yabar, CA; Acuna, M; Gazzo, C; Salinas, G; Cardenas, F; Valverde, A; Romero, S
AIDS Research and Human Retroviruses, 28(): 1712-1722.
10.1089/aid.2012.0040
CrossRef
AIDS Research and Human Retroviruses
Recombination Between Variants from Genital Tract and Plasma: Evolution of Multidrug-Resistant HIV Type 1
Kemal, KS; Ramirez, CM; Burger, H; Foley, B; Mayers, D; Klimkait, T; Hamy, F; Anastos, K; Petrovic, K; Minin, VN; Suchard, MA; Weiser, B
AIDS Research and Human Retroviruses, 28(): 1766-1774.
10.1089/aid.2011.0383
CrossRef
Plos One
HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies
Kiwelu, IE; Novitsky, V; Margolin, L; Baca, J; Manongi, R; Sam, N; Shao, J; McLane, MF; Kapiga, SH; Essex, M
Plos One, 7(): -.
ARTN e47605
CrossRef
AIDS
HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy
Weiser, B; Philpott, S; Klimkait, T; Burger, H; Kitchen, C; Bürgisser, P; Gorgievski, M; Perrin, L; Piffaretti, J; Ledergerber, B; the Swiss HIV Cohort Study,
AIDS, 22(4): 469-479.
10.1097/QAD.0b013e3282f4196c
PDF (194) | CrossRef
AIDS
Routine HIV-1 genotyping as a tool to identify dual infections
Cornelissen, M; Jurriaans, S; Kozaczynska, K; Prins, JM; Hamidjaja, RA; Zorgdrager, F; Bakker, M; Back, N; van der Kuyl, AC
AIDS, 21(7): 807-811.
10.1097/QAD.0b013e3280f3c08a
PDF (90) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
A Dual Superinfection and Recombination Within HIV-1 Subtype B 12 Years After Primoinfection
Pernas, M; Casado, C; Fuentes, R; Pérez-Elías, MJ; López-Galíndez, C
JAIDS Journal of Acquired Immune Deficiency Syndromes, 42(1): 12-18.
10.1097/01.qai.0000214810.65292.73
PDF (605) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Transition From Long-Term Nonprogression to HIV-1 Disease Associated With Escape From Cellular Immune Control
Rowland-Jones, S; Burger, H; Kemal, KS; Beattie, T; Dong, T; Weiser, B; Kaul, R; Kuiken, C; Sutton, J; Lang, D; Yang, H; Peng, YC; Collman, R; Philpott, S
JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(2): 119-126.
10.1097/QAI.0b013e31816b6abd
PDF (352) | CrossRef
Back to Top | Article Outline
Keywords:

HIV-1; recombination; superinfection; Africa; vaccine; women

© 2004 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.